Multimodal Assessment of Neuromuscular Electrical Stimulation (NMES) Effects on Respiratory and Peripheral Muscles in Chronic Obstructive Pulmonary Disease (COPD) (NMES in COPD)
Comparative Effects of Targeted Neuromuscular Electrical Stimulation (NMES) on Respiratory and Peripheral Muscles in Patients With Chronic Obstructive Pulmonary Disease (COPD): A Multimodal Assesment Using Diaphragm Ultrasound and Plasma Biomarkers (Interleukin-6 and Insulin-like Growth Factor- 1)
The goal of this clinical trial is to learn if targeted neuromuscular electrical stimulation (NMES) can treat respiratory and peripheral muscle weakness in patients with chronic obstructive pulmonary disease (COPD). The main questions it aims to answer are:
- Does targeted NMES improve diaphragm thickening fraction and excursion as measured by diaphragm ultrasound?
- What are the comparative effects of targeted NMES on plasma biomarkers, specifically Interleukin-6 (IL-6) and Insulin-like Growth Factor-1 (IGF-1)? Researchers will compare three groups: the first intervention group receiving intercostal NMES combined with Pursed-Lip Breathing (PLB), the second intervention group receiving quadriceps NMES combined with PLB, and a control group receiving sham upper trapezius NMES combined with PLB, to see if targeted NMES provides superior improvements in respiratory and peripheral muscle function.
Participants will:
- Undergo baseline screening, including a diaphragm ultrasound and a blood draw for plasma biomarkers (IL-6 and IGF-1)
- Be randomly assigned to one of the three groups to receive either intercostal NMES, quadriceps NMES, or sham upper trapezius NMES, all combined with Pursed-Lip Breathing exercises
- Complete a post-intervention assessment involving repeat ultrasound imaging and biomarker analysis to evaluate muscle and systemic changes
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Chronic Obstructive Pulmonary Disease (COPD) is characterized by chronic airflow limitation and progressive respiratory and peripheral muscle dysfunction. While pulmonary rehabilitation is a cornerstone of management, severe breathlessness often limits a patient's exercise tolerance. Neuromuscular Electrical Stimulation (NMES) offers an alternative modality to train specific muscle groups without inducing severe dyspnea. However, the comparative efficacy of stimulating respiratory muscles versus peripheral muscle groups requires deeper investigation using precise physiological and biochemical markers.
This study utilizes a three-arm randomized controlled design to evaluate and compare the localized and systemic effects of targeted NMES. The mechanical properties of the respiratory system will be monitored using diaphragm ultrasound, focusing on active contractility and movement. Concurrently, systemic inflammation and muscle anabolic responses will be analyzed through plasma biomarkers to understand the underlying biomolecular pathways.
Upon meeting the eligibility criteria and providing written informed consent, the 45 participants will be randomly assigned to one of three study arms in a 1:1:1 ratio. All participants will undergo a standardized baseline assessment. Following the allocation, each group will complete their designated 8-week intervention protocol consisting of 3 sessions per week (total of 24 sessions) concurrently with Pursed-Lip Breathing (PLB) training. A comprehensive post-intervention reassessment will be conducted immediately following the final session to determine the comparative physiological and biochemical outcomes.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Dian Marta Sari, Physiatrist
- Numero di telefono: +62 812 2181 227
- Email: dian.marta@unpad.ac.id
Luoghi di studio
-
-
West Java
-
Bandung, West Java, Indonesia
- Reclutamento
- Faculty of Medicine Universitas Padjadjaran
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients diagnosed with stable Chronic Obstructive Pulmonary Disease (COPD), GOLD spirometric grade 2-4 (post-bronchodilator FEV1/FVC <0.70 with FEV1 <80% predicted), confirmed by a pulmonologist.
- Age ≥ 40 years old.
- Willing to participate in the study and sign the written informed consent form.
Exclusion Criteria:
- Recent thoracic or abdominal surgery, pneumothorax, or a history of spontaneous pneumothorax.
- Participation in other structured respiratory muscle training or pulmonary rehabilitation programs that may confound the study results.
- Presence of neuromuscular, bulbar, laryngeal, or other disorders that may independently impair respiratory muscle function.
- Use of a cardiac pacemaker or any metal/electronic implant at the intended stimulation area.
- Diagnosis of heart failure classified as NYHA (New York Heart Association) class III-IV.
- Presence of skin lesions, open wounds, or active dermatitis in the intended electrode placement areas.
- Current use of systemic (oral) corticosteroids or history of use within 4 weeks prior to enrollment.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Intercostal NMES + PLB
Participants receive targeted NMES to the intercostal muscles combined with Pursed-Lip Breathing (PLB) exercises. The protocol is administered 3 times per week for 8 weeks. |
Intercostal Neuromuscular Electrical Stimulation (NMES) is a procedure that uses small electrical impulses delivered through electrodes on the skin to stimulate motor nerves and cause passive muscle contractions which will be applied to the intercostal muscles Pursed-lip breathing is a simple respiratory exercise that involves inhaling slowly through your nose and exhaling gently through tightly puckered or "pursed" lips (as if whistling or blowing out a candle). |
|
Sperimentale: Quadriceps NMES + PLB
Participants receive targeted NMES to the quadriceps muscles combined with Pursed-Lip Breathing (PLB) exercises. The protocol is administered 3 times per week for 8 weeks. |
Pursed-lip breathing is a simple respiratory exercise that involves inhaling slowly through your nose and exhaling gently through tightly puckered or "pursed" lips (as if whistling or blowing out a candle). Quadriceps Neuromuscular Electrical Stimulation (NMES) is a procedure that uses small electrical impulses delivered through electrodes on the skin to stimulate motor nerves and cause passive muscle contractions which will be applied to the quadriceps muscles |
|
Comparatore placebo: Sham NMES + PLB
Participants receive sham NMES to the upper trapezius muscles combined with Pursed-Lip Breathing (PLB) exercises. The protocol is administered 3 times per week for 8 weeks. |
Pursed-lip breathing is a simple respiratory exercise that involves inhaling slowly through your nose and exhaling gently through tightly puckered or "pursed" lips (as if whistling or blowing out a candle). Sham Neuromuscular Electrical Stimulation (NMES) is a control procedure that delivers minimal electrical impulses via transcutaneous skin patches to the upper trapezius muscles, generating only a mild tingling sensation as a placebo effect without triggering any passive muscle contractions. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Diaphragm Excursion (DE)
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
Measured via B-mode or M-mode transabdominal ultrasound during quiet and deep breathing to evaluate the distance the diaphragm travels vertically. A higher excursion value indicates better diaphragmatic mobility. |
Baseline (Week 0) and post-intervention (Week 8)
|
|
Diaphragm Thickening Fraction (TF)
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
Calculated using the formula: [(Thickness at end-inspiration - Thickness at end-expiration) / Thickness at end-expiration] x 100%. Measured via high-frequency linear ultrasound at the zone of apposition to assess diaphragmatic contractile function. |
Baseline (Week 0) and post-intervention (Week 8)
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Plasma Interleukin-6 (IL-6) Levels
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
Measured via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to evaluate systemic inflammatory profiles. Decreased levels indicate a reduction in systemic inflammation. |
Baseline (Week 0) and post-intervention (Week 8)
|
|
Change in Plasma Insulin-like Growth Factor-1 (IGF-1) Levels
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
Measured via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to evaluate muscle anabolic activity and systemic growth factor response. Increased levels indicate an improved anabolic state. |
Baseline (Week 0) and post-intervention (Week 8)
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Six-Minute Walk Test (6MWT) Distance
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
Measured by the total distance in meters that a participant can walk quickly on a flat, hard surface in a period of 6 minutes. It evaluates functional exercise capacity. |
Baseline (Week 0) and post-intervention (Week 8)
|
|
Modified Medical Research Council (mMRC) Dyspnea Scale
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
A questionnaire used to rate the baseline dyspnea (breathlessness) on a scale from 0 (breathless only with strenuous exercise) to 4 (too breathless to leave the house). Lower scores indicate less respiratory disability. |
Baseline (Week 0) and post-intervention (Week 8)
|
|
COPD Assessment Test (CAT) Score
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
An 8-item questionnaire measuring the health status impairment in COPD patients. Scores range from 0 to 40, where higher scores signify a worse health status and severe impact of COPD on the patient's life. |
Baseline (Week 0) and post-intervention (Week 8)
|
|
Modified Borg Scale (MBS) for Dyspnea
Lasso di tempo: Baseline (Week 0) and post-intervention (Week 8)
|
A categorical scale ranging from 0 (no breathlessness at all) to 10 (maximal breathlessness) used to assess the patient's perceived level of shortness of breath during functional activity or rest. |
Baseline (Week 0) and post-intervention (Week 8)
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Manifestazioni neurologiche
- Malattie muscoloscheletriche
- Malattie del sistema nervoso
- Malattie muscolari
- Manifestazioni neuromuscolari
- Processi patologici
- Malattia cronica
- Attributi della malattia
- Malattie delle vie respiratorie
- Malattie polmonari
- Malattie polmonari, ostruttive
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Malattia polmonare, cronica ostruttiva
- Debolezza muscolare
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- IKFR-202609.01
- 004/PEG-PRJ/SL/UKM/X/2026 (Altro numero di sovvenzione/finanziamento: Maranatha Christian University)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data will not be made publicly available to protect participant privacy
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .